The FDA removed Lillys tirzepatide from the drug shortage list in December 2024 and Novos semaglutide in February this year
If this sounds like a delivery service you want even more of, you might want to look into l-carnitine supplements
That trial measured hormone levels rather than body composition, so downstream effects on fat and lean mass are not established by it
[3] [4] Because retatrutide is unlicensed, it may only be supplied to a patient in the UK on a named-patient basis a route known as an unlicensed 'Special' where a registered prescriber takes personal responsibility for its use, confirms that no suitable licensed alternative exists, and ensures the patient is fully informed of its unlicensed status
However, 503A compounding pharmacies operate under strict FDA oversight and state licensing
If new breakouts persist beyond the second week after treatment, contact your provider